Facts about the FYR SARS-CoV-2 Multiplex RT-PCR Test:

• FYR SARS-CoV-2 Multiplex RT-PCR Test has many improvements that increase performance and sensitivity compared to the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Test.
• FYR SARS-CoV-2 Multiplex RT-PCR Test utilizes three viral gene targets. This will prevent any loss of performance from mutations present in variants.
• FYR SARS-CoV-2 Multiplex RT-PCR Test is performed in a multiplex format so that all viral gene targets and the human genetic material control occur in a single reaction instead of multiple reactions.
• For more details, please visit this fact sheet for providers and this fact sheet for patients.

Facts about RT-PCR testing from the CDC:

• The CDC 2019-nCoV Real-Time RT-PCR Diagnostic Test is authorized for use in the US in accredited CLIA certified labs (like us!).
• The CDC 2019-nCoV Real-Time RT-PCR Diagnostic Test can be used to test upper and lower respiratory specimens.
• A positive test result means that RNA from SARS-CoV-2 was detected and the patient is presumed to be infected and may be contagious.
• CDC 2019-nCoV Real-Time RT-PCR Diagnostic Test minimizes the likelihood of false positive results.
• For more details, please visit this fact sheet!

One of our team members created a resource to answer all your COVID-19 questions! Check it out at: fyrcovidresource.info/